Compare ARK Genomic Revolution ETF (ARKG) vs Home Depot Inc (HD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Home Depot Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Home Depot Inc trades at $342.67 (market cap $342.31B). The key difference: Home Depot Inc pays a 2.71% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Home Depot Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | HD | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $423.42 |
52-Week Low | $23.09 | $297.51 |
Market Cap | — | $342.31B |
Enterprise Value | — | $403.87B |
Dividend Yield | — | 2.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Home Depot (HD) trades at $343.30, up 1.35% with mixed technical signals showing bearish overall momentum but bullish moving averages. The company reported solid Q1 2026 earnings beat ($3.43 actual vs $3.41 expected) and maintains strong profitability with 33.13% gross margins. Recent institutional activity shows mixed positioning while analyst consensus remains bullish with a $370.59 price target, representing 7.9% upside potential from current levels.
HD faces near-term headwinds from weakening big-ticket demand and margin pressure, but strong Pro business growth and housing market tailwinds support long-term prospects. The stock's current valuation at 24.38 P/E appears reasonable given consistent profitability and market leadership position. Key risks include rising mortgage rates impacting home improvement spending and competitive pressures in the retail sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →
